Shufro Rose & CO LLC Eli Lilly & CO Transaction History

Shufro Rose & CO LLC

$1.22 Billion
Q2 2024

A detailed history of Shufro Rose & CO LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Shufro Rose & CO LLC holds 47,751 shares of LLY stock, worth $42.4 Million. This represents 3.55% of its overall portfolio holdings.

Number of Shares

47,751

Previous 45,584 4.75%

Holding current value

$42.4 Million

Previous $35.5 Million 21.91%

% of portfolio

3.55%

Previous 2.96%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $1.57 Million - $1.97 Million	2,167 Added 4.75%	47,751 $43.2 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $2,961 - $3,961	-5 Reduced 0.01%	45,584 $35.5 Million
Q3 2023 Oct 25, 2023	SELL	$434.7 - $599.3 $2,173 - $2,996	-5 Reduced 0.01%	45,589 $24.5 Million
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $143,803 - $192,281	-410 Reduced 0.89%	45,594 $21.4 Million
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $112,448 - $132,064	-362 Reduced 0.78%	46,004 $15.8 Million
Q4 2022 Jan 25, 2023	BUY	$321.55 - $374.67 $1,286 - $1,498	4 Added 0.01%	46,366 $0
Q3 2022 Oct 24, 2022	BUY	$296.48 - $337.87 $31,723 - $36,152	107 Added 0.23%	46,362 $15 Million
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $5,574 - $6,545	-20 Reduced 0.04%	46,255 $15 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $23,938 - $29,749	102 Added 0.22%	46,275 $13.3 Million
Q3 2021 Nov 05, 2021	BUY	$221.6 - $272.71 $4,432 - $5,454	20 Added 0.04%	46,173 $10.7 Million
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $27,396 - $36,252	-210 Reduced 0.45%	46,153 $7.79 Million
Q3 2020 Oct 27, 2020	BUY	$146.22 - $169.13 $36,701 - $42,451	251 Added 0.54%	46,363 $6.86 Million
Q4 2019 Jan 28, 2020	SELL	$106.92 - $132.43 $75,057 - $92,965	-702 Reduced 1.5%	46,112 $6.06 Million
Q3 2019 Oct 30, 2019	SELL	$106.79 - $116.16 $4,591 - $4,994	-43 Reduced 0.09%	46,814 $5.24 Million
Q2 2019 Jul 24, 2019	BUY	$110.79 - $129.32 $4,763 - $5,560	43 Added 0.09%	46,857 $5.19 Million
Q1 2019 May 03, 2019	SELL	$111.31 - $131.02 $17,253 - $20,308	-155 Reduced 0.33%	46,814 $6.08 Million
Q4 2018 Feb 01, 2019	SELL	$105.9 - $118.64 $6,883 - $7,711	-65 Reduced 0.14%	46,969 $5.44 Million
Q1 2018 May 04, 2018	SELL	$74.21 - $87.6 $88,235 - $104,156	-1,189 Reduced 2.47%	47,034 $3.64 Million
Q4 2017 Feb 06, 2018	SELL	$81.94 - $87.89 $39,085 - $41,923	-477 Reduced 0.98%	48,223 $4.07 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $3.75 Million - $4.17 Million	48,700	48,700 $4.17 Million

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shufro Rose & CO LLC with notifications on news.

Account

Shufro Rose & CO LLC Eli Lilly & CO Transaction History